<scp>NOTCH</scp>, <scp>ASCL1</scp>, p53 and <scp>RB</scp> alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas
Lydia Meder(Friedrich-Alexander-Universität Erlangen-Nürnberg), Reinhard Buettner(University of Cologne)
Cited by 177
Related Papers
Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas
|Modern Pathology|2016|347
Drugging the catalytically inactive state of RET kinase in RET-rearranged tumors
|Science Translational Medicine|2017|64